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We have developed a reliable and sensitive immunohisto-
chemical staining technique which allows the simultaneous 
demonstration of two different antigens expressed in or on 
the same cell (referred to as mixed labeling) , together with 
the evaluation of the general histopathological appearance 
of the tissue. The staining procedure combines a three-step 
(streptavidin-biotin) immunogold-silver staining (IGSS) 
with a three-step immunoenzymatic labeling. For this pur-
pose, we investigated the compatibility ofIGSS with various 
substrates of peroxidase or alkaline phosphatase (AP). Highly 
reliable and discernible mixed labeling was achieved only 
after iniriallabeling with IGSS followed by AP labeling using 
the substrates naphthol AS-MX phosphate/Fast Blue or 
naphthol AS-HI phosphate/New Fuchsin, respectively. To 
Introduction 
Double immunoenzymatic labeling (IEL) of cryostat sections has 
become a widely applied technique in immunohistology since its 
first description (23). Its major advantage is based on the possibil-
ity of studying both labels simultaneously. This is in contrast to 
double immunofluorescence (IF) procedures (17 ,30), in which the 
use of different filters and the invisibility of the general histology 
during fluorescence microscopy constitute considerable disadvan-
tages. In addition, the fading of color signals does not allow long-
term documentation and retrospective evaluation of IF-stained tis-
sue samples. On the other hand, the use of double IEL methods 
for identification of two different surface or cytoplasmic antigens 
of the very same cell or of other tissue components (referred to as 
mixed labeling) is associated with fundamental difficulties that have 
not yet been overcome (4,19). Thus far, all the enzymatic color reac-
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ensure utmost specificity, we applied FlTC-conjugated mouse 
monoclonal antibodies and rabbit anti-FlTC immunoglob-
ulins visualized by AP-labeled immunoglobulins and the 
respective substrate in a final step. This novel approach pro-
vides an excellent means for demonstration of immuno-
competent cells and unequivocal determination of the per-
centage of specific cell subsets in infiltrated tissue. The 
advantages of this method, as compared with double im-
munofluorescence or double immunoenzymatic labeling, 
were investigated and are discussed. (J Histochem Cytochem 
38:307-313, 1990) 
KEY WORDS: Immunohistochemistry; Immunogold-silver staining; 
FITC- anti-FITC system; Leucocyte subpopulations; Two-color staining. 
tions that have been combined either interfered with each other 
or resulted in markedly decreased sensitivity (24). These are the 
major reasons for the more frequent use of double IF staining proce-
dures despite the disadvantages mentioned above. 
In a variety of diseases, analysis of immunocompetent cells in-
filtrating the affected tissue is important for understanding the 
pathogenetic mechanisms (25,26,28). In addition to the identifi-
cation of various lymphocyte populations (B-cells, CD4+ and CD8+ 
T -cells), the demonstration oflymphocyte subsets expressing mem-
ory or activation antigens (interleukin-2 receptor, HLA-DR anti-
gen, CD44, CD45RO, transferrin receptor) is of utmost significance. 
Our interests focus on the analysis of these subsets in various skin 
disorders (acute and chronic skin inflammation, autoimmune dis-
orders) to evaluate their role in the course of disease and to gain 
further insight into the immunopathological mechanisms that be-
come effective. In view of the importance for these analyses of a 
mixed labeling system, we investigated the possibility of a novel 
staining protocol combining an IGSS (9,15) with an immunoen-
zymatic method. We evaluated the various combinations of IGSS 
and either peroxidase (POX) or alkaline phosphatase (AP) label-
ing, using different substrates for the enzymatic reactions. Our 
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results demonstrate that only the initial staining with IGSS, fol-
lowed by AP staining with the substrates naphthol AS-MX phos-
phate (NAMP)/Fast Blue or naphthol AS-BI phosphate (NABP)/ 
New Fuchsin, resulted in excellent mixed labeling. All other com-
binations tested did not produce satisfactory results. In addition 
to the three-step IGSS (6,7), the appli.cation of FITC-conjugated 
monoclonal antibodies (MAb) and rabSit anti-FITC immunoglob-
ulins (Ig) (14,31,32) detected by AP-Iabeled anti-rabbit Ig ensured 
the high sensitivity of the second label. As a result, immunocompe-
tent cells that are positive for one or for two antigens are clearly 
discernible. This novel method therefore combines the aforemen-
tioned advantages of both double lEL and double IF. 
Materials and Methods 
Preparation of Skin Sections. Fresh human biopsy specimens of inflamed 
skin were obtained for routine hisrology from patients suffering from atopic 
dermatitis, eczema, and mucosis fungoides . Some of the material was snap-
frozen in Tissue-Tek OCT compound (Miles Scientific; Naperville, IL) using 
isopentane pre-cooled in liquid nitrogen. Cryostat secrions (4 Ilm) were 
thawed onto slides coated with Histostik (Accurate Chemicals; San Diego, 
CA), air-dried, and fixed in acetone (4'C, 10 min). Gelatin-coated slides 
are not recommended for IGSS. To clear slides from OCT compound and 
to block nonspecific reactions, they were rinsed in a solution (Blotto) con-
taining 5% skim milk powder and 0.1% Tween 20 in PBS, pH 7.4. Blotto 
was used in all further washing steps unless otherwise stated. For blocking 
ofFc receptors, sections were pre-incubated for 20-30 min at room temper-
ature (RT) in Blotto containing 20% sheep serum. 
Mouse MAb, Conjugated Polyclonal Antibodies, and Conjugates. All 
MAb applied in rhe present srudy are commonly used and all reagents are 
commercially available. The dilutions and sources of antibodies and con-
jugates are summarized in Table l. 
IGSS. For IGSS (8), a three-step procedure according to Coggi et al. 
(7) and Bronckers et al. (6) was used in all experiments. The sections were 
incubated with the first-srep antibodies (for dilution see Table I) for 10- 14 
hr (overnight) at 4'C. Thereafter, the slides were thoroughly washed in Blotto 
three times and the biotin-conjugated second-stage antibodies were allowed 
to remain on the sections for I hr at RT. After a brief wash in Blotto, all 
Table 1. Antibodies and Conjugates 
Antibodies! complexes 
Anti-HLA-DR 
Anti-HLA-DR, FITC-conjugated 
Anti-CD45RO (UCHL-I) 
Anti-CD45RO (UCHL-l), FITC-conjugated 
Anti-CD45 (HLe) 
Anti-CD45 (HLe) , FITC-conjugated 
Anti-Leu-4 (CD3), FITC-conjugated 
Anti-Leu-2a (CD8), FITC-conjugated 
Anti-mouse Ig, biotin-conjugated 
Rabbit anti-FITC Ig 
Goat anti-rabbit Ig, POX-conjugated 
Goat anti-rabbit Ig , AP-conjugated 
Donkey anti-rabbit Ig, FITC-conjugated 
Streptavidin-conjugated gold 
Streptavidin-conjugated Texas Red 
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following washes were performed in Tris rinsing buffer (0.05 M, pH 7.6) 
containing Tween 20 (0.1 %) and BSA (0.2%). Streptavidin-conjugated gold 
was overlaid for I hr at RT, and after three washes in Tris rinsing buffer 
followed by three washes in distilled water, freshly prepared silver enhance-
ment mixture Intense SE TM II Oanssen Life Science; Olen, Belgium) was 
applied for 5- 12 min. The silver enhancement process was monitored un-
der the microscope using brightfield or epipolarization illumination (10). 
POX/AP IEL. The sections were incubated with FITC-conjugated an-
tibodies (Table I) overnight at 4'C and were subsequently labeled with rabbit 
anti-FITC Ig and sheep anti-rabbit Ig conjugated with POX or AP. Between 
each incubation step (RT, I hr), the sections were rinsed with Blotto, and 
in the final washing step, before addition of substrates, with Tris rinsing 
buffer. The labeling was visualized with the substrates diaminobenzidine 
(DAB) (Sigma Chemicals; St Louis , MO) and 3-amino-9-ethylcarbazole 
(AEC) (Sigma) for the POX reaction, and NAMP/Fast Red (Sigma), 
NAMP/Fast Blue (Sigma), NABP/New Fuchsin (Sigma; or Merck, Darm-
stadt, FRG), and bromochloro-indolyl-phosphate (BCIP)/nitroblue tetrazo-
lium (NBT) (Sigma) for the AP reaction. The DAB solution (12,16) con-
tained 0.5 mg/ml DAB, 0.01% (w/v) cobalt chloride, 6.8 mg/ml imidazole 
(29), and 0.03% (v/v) H202 in PBS (pH 7.4), and the AEC solution (13) 
contained 0.2 mg/ml AEC, previously dissolved in N,N-dimethylformamide 
(final concentration 5%), 0.015% H202 in acetate buffer (50 mM, pH 5). 
The NAMP/Fast Red and NAMP/Fast Blue solutions contained 0.2 mg/ml 
NAMP dissolved in N,N-dimethylformamide (final concentration 2%), 
I mM levamisole, and I mg/ml Fast Red TR salt or Fast Blue TR salt, respec-
tively, in Tris buffer (0.1 M, pH 8.2). The NABP/New Fuchsin solution (22) 
consisted ofO. 5 mg /ml NAPB dissolved in N,N-dimethylformamide (final 
concentration 0.5%),6 mM sodium nitrite, I mM levamisole, and 4% (w/v) 
New Fuchsin (stock solution diluted in 2 M HCI) in Tris buffer (0.2 M, 
pH 9.0). The BCIP/NBT solution (20) contained 0.38 M BCIP (50 mg /ml 
dissolved in N,N-dimethylformamide) and 0.4 M NBT (75 mg/ml dissolved 
in 70% N,N-dimethylformamide) in lCis-buffered saline (lOO mM , pH 9.5). 
The substrate solutions were filtered onto the slides and color development 
was stopped after 2 min in the case of DAB and after 5-20 min when other 
substrates were used. 
Combination ofIGSS With POX/AP Labeling. For the mixed label-
ing with IGSS and IEL, the following sequence of treatments was shown 
to give the best results: Blotto containing 20% sheep serum (20-30 min, 
RT); mouse MAb for first (IGSS) labeling (overnight, 4'C); biotinylated 
Dilution 
1130-11100 
1160-11200 
1130-1160 
1160-11100 
1130-11100 
1160-11100 
1130-11100 
1130-11100 
1/100-11200 
11500-111000 
11200 
11200 
11200 
1140-1150 
1150 
Source 
Becton-Dickinson (Sunnyvale , CA) 
Becton-Dickinson 
Dakopatts (Copenhagen , Denmark) 
Dakopatts 
Becton-Dickinson 
Becton-Dickinson 
Becton-Dickinson 
Becton-Dickinson 
Amersham (Amersham, UK) 
Easr Acres Chemicals (Southbridge, MA) 
Accurate Chemicals (San Diego, CA) 
Accurate Chemicals 
Jackson Immuno Research 
(Avondale, PA) 
Janssen (Olen, Belgium) 
Amersham 
PAIRED IGSS-IMMUNOENZYMATIC DOUBLE LABELlNG 
Figure 1. (A) Dermal vessels stained for 
HLA-DR antigen expression by a three-step 
IEL with a final AP-conjugated Ab and 
NAMP/Fast Red as substrate; hematoxylin 
counterstaining. (8) The same area as in A 
under epipolarization illumination shows an 
intrinsic shining of the NAMP/Fast Red color 
product similar to IGSS. (C) Dermal vessel 
stained for HLA-DR antigen as in A, but with 
NABP/New Fuchsin as substrate; hematox-
ylin counterstaining. (D) Same area as in C 
under epipolarization illumination shows no 
intrinsic incident polarized light reflection . 
Bar = 25 ~m. 
Figure 2. (A) Skin section with mycosis fun-
goides stained for CD3 with IGSS and for 
HLA-DR with AP-NAMP/Fast Blue. The fig-
ure shows mutually exclusive expression of 
the two antigens, with only a few cells be-
ing doubly positive (arrowhead). Brightfield 
illumination. (8) NAMP/Fast Blue labeling 
does not show incident polarized light reflec-
tion and therefore does not interfere with 
IGSS. Bar = 25 ~m. 
Figure 3. Double staining with IGSS (CD8) 
and AP-NAPB/New Fuchsin (HLA-DR) in a 
skin lesion of atopic dermatitis (A) under 
brightfield illumination. (8) Only a few cells 
co-express both antigens and are therefore 
IGSS positive (epipolarization illumination). 
(C) The same tissue stained with AP-NAMPI 
New Fuchsin (CD45) and IGSS (HLA-DR) 
under brightfield and (D) under epipolariza-
tion illumination. Bars: A = 25 ~m; C = 16 
~m. 
, 
sheep anti-mouse Ig antibodies (1 hr, RT); streptavidin-conjugated gold 
(1 hr, RT); blocking with 10% mouse serum in Blotto (20 min, RT); FITC-
conjugated MAb for the second labeling (lEL) (overnight, 4°C or 2 hr at 
RT); rabbit anti-FITC Ig (1 hr, RT); POX/AP-conjugated goat anti-rabbit 
Ig (1 hr, RT), IGSS enhancement mixture (5-12 min, RT); POX/AP sub-
strate (2-20 min). The IGSS enhancement, as well as the AP-substrate reac-
tion, should be monitored from time ro time under a microscope. 
Double IF. For double IF, streptavidin-conjugated Texas Red was used 
instead of streptavidin-conjugated gold (see Table 1), and FITC-conjugated 
donkey anti-rabbit Ig antibodies (Table 1) instead of enzyme-conjugated 
antibodies. 
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Counterstaining and Microscopic Analysis of Sections. The sections were 
counterstained with hematoxylin, where indicated and mounted (Gurr Aqua-
mount; BDH, Pooie, UK). For evaluation a Zeiss Axiophot microscope 
equipped for polarized incident light (epipolarization) microscopy (Zeiss; 
Oberkochen, FRG) was used. 
Results 
Single lGSS and Single lEL 
For one-color staining with either IGSS or IEL, our results confirmed 
310 
previous reports on these methods (6,7,10,1'». The three-step pro-
cedure used for IEL was based on an FITC-anti-FITC system 
(14,31,32) employing the fluorochrome as a hapten, and showed 
very specific staining regardless of the fluorochrome/protein ratio 
of the fluoresceinated MAb. The use of Blotto as rinsing buffer 
(manuscript in preparation) was particularly beneficial for the signal-
to-noise ratio, because it significantly reduced the background stain-
ing for both labeling procedures. For all the primary MAb used 
we found a significantly higher sensitivitiy for IEL as compared with 
IGSS. For IEL, the MAb could be used in a three- to fivefold higher 
dilution. Epipolarization microscopy, although lowering the de-
tection threshold of gold-Iabeled antigens for IGSS, could not fully 
compensate for the high sensitivity of the three-step IEL, which 
is comparable to three-step streptavidin-biotin POX/AP methods 
in terms of sensitivity. 
lGSS Combined With lEL 
When, after establishing the conditions for IGSS and IEL, both 
staining protocols were combined for double labeling, the sequence 
of labeling was found to be critical for specificity and sensitivity. 
Performance of IEL before IGSS produced nonspecific IGSS sig-
nals of cells already labeled with the substrates of POX or AP (results 
not shown). This can be partly explained by silver precipitation 
on the color substrates of the preceding IEL. However, a highly spe-
cific color enzyme reaction was obtained using the IGSS procedure 
before the more sensitive !EL. The latter yields specific and stronger 
signals of the second antigen to be detected. For these reasons, IGSS 
without silver enhancement was carried out first in all further dou-
ble mixed labeling experiments, followed by !EL, whereby the sil-
ver enhancement was performed before the AP/POX-substrate reac-
tion . The combination of IGSS with POX labeling, using DAB as 
substrate, resulted in double staining with poorly discernible color 
products. In contrast, the POX substrate AEC yields a red reaction 
product and therefore appeared more suitable to be combined with 
IGSS. However, the POX reaction with AEC almost completely neu-
tralized the IGSS and resulted in insufficient staining. In summary, 
the two most widely used POX substrates are not compatible with 
IGSS for double mixed labeling. 
For this purpose, in the next series of experiments, an AP stain-
ing protocol for the second antigenic determinant was established 
which would be suitable for combination with IGSS. The four most 
commonly used substrates, NAMP/Fast Red, NAMP/Fast Blue, 
NABP/New Fuchsin, and BCIP/NBT, were applied . All substrates 
perfectly visualized the antigenic determinant (e.g. , HLA-DR). As 
could be expected , the dark purple color product of BCIP/NBT 
was difficult to discriminate from IGSS under light microscopic 
visualization and therefore is not an appropriate substrate for mixed 
labeling. NAMP/Fast Red was not suitable for this purpose either. 
Under brighrfield illumination, its red reaction product was clearly 
visible (Figure lA) and could be expected to contrast well with the 
brown color ofIGSS; however, the NAMP/Fast Red reaction prod-
uct reflected polarized incident light (Figure lE) in a way similar 
to IGSS. Under epipolarization illumination, only NABP/New Fuch-
sin (Figure ID) and NAMP/Fast Blue (Figure 2B) did not exhibit 
any intrinsic polarized light reflection and nevertheless contrasted 
well with IGSS under brighrfield illumination (Figures 2,3, and 4). 
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Therefore, various combinations ofMAb to be utilized for mixed 
labeling were examined using NAMP/Fast Blue and NABP/New 
Fuchsin as substrates for AP. Both substrates performed equally 
well in terms of sensitivity, but the preparation ofNAMP/Fast Blue 
is simpler and less time consuming. To find out whether this mixed 
labeling procedure is specific and sensitive enough to detect anti-
gens that are co-expressed on immunocompetent cells, we applied 
the corresponding MAb in two reciprocal combinations ("reversed 
order incubation"). For example, HLA-DR expression was traced 
with IGSS and CD4') expression with AP, as well as vice versa. Sub-
sequently, all the singly and doubly positive cells were counted in 
both sections. We found an identical distribution of single- and 
double-Iabeled cells (data not shown). This result clearly demon-
strated the high specificity of the presented mixed labeling method. 
By this technique, singly and doubly positive cells could even be 
distinguished under epipolarization illumination. IGSS single-
labeled cells displayed yellow bright grains, whereas cells addition-
ally labeled with AP (NAMP/Fast Blue) showed a shift of the bright 
yellow color towards a bright blueish color (Figures 4C, 4D, ')A, 
and 5B). This beneficial effect was primarily seen with NAMP/Fast 
Blue, which was therefore used preferentially. 
In summary, the mixed labeling is a powerful tool to define 
singly and doubly positive cells in frozen sections. Using this tech-
nique, we can analyze the distribution of activated T -Iymphocytes 
in inflammatory lesions by staining for CD3 or CD8 and CD4')RO 
expression (Figures ')A, and 5B). CD 3+ cells are visualized by IGSS, 
and the relatively high proportion of activated cells are co-expressing 
CD4')RO, which is unambiguously seen by the additional blue AP 
label. 
The sensitivity of mixed labeling was compared to double IF, 
for which AP and gold conjugates were replaced by FITC and Texas 
Red conjugates, respectively (data not shown). As judged by the 
dilution of the primary Ab, the sensitivity of IF was similar or up 
to two times higher for tracing the first antigen. For detection of 
the second antigen, however, the sensitivity of mixed labeling was 
two to three times higher. 
Discussion 
In the present study we demonstrated a novel combination ofIGSS 
with !EL which allows simultaneous and unambiguous demonstra-
tion of antigens co-expressed on the same cell. This techpiq'ue is 
referred to as mixed labeling. The staining protocol developed al-
lows highly specific and sensitive double labeling, provided that 
IGSS is performed before IEL. Among many AP-specific substrates 
tested, only NAMP/Fast Blue and NABP/New Fuchsin revealed sig-
nals that did not interfere with IGSS under either brightfield or 
epipolarization illumination. The use ofFITC-conjugated primary 
MAb for IEL (31,32) prevents any crossreactivity with the antigen 
detected by IGSS and supports the specificity of the procedure. 
The designed method does not require conjugation of primary MAb 
with haptens such as arsanilic acid (11), which bears the inherent 
risk of loss of antibody activity or inefficient coupling. The applica-
bility and practicability is facilitated by the utilization of commonly 
and commerically available substances. For this reason, it can eas-
ily be applied for routine work and diagnostic purposes. 
As compared with double IF techniques (24), this new method 
PAIRED IGSS- IMMUNOENZYMATIC DOUBLE LABELING 
Figure 4. Double staining for CD45 (IGSS) 
and HLA-DR (AP-NAMP/Fast Blue) in a skin 
section of mycosis fungoides. (A) A high per-
centage of cells are doubly positive for CD45 
and HLA-DR under brightfield illumination 
and (8) under epipolarization illumination. 
(C, D) The same section with higher mag-
nification. Single IGSS-positive cells show 
yellow grains, whereas double-Iabeled cells 
are light blue. Bars: A ; 251lm; C ; 161lm. 
Figure 5. Double staining for CD3 (IGSS) 
and CD45RO (AP-NAMP/Fast Blue). Detail 
with two CD3' lymphOCy1es. One Iympho-
cy1e is activated (CD45RO+), demonstrated 
by the additional blue label (A), which ap-
pears light blue under epipolarization illumi-
nation (8). Bar; 16 Ilm. 
offers several important advantages. First, both color products of 
the mixed labeling are visible under the same lighting (brightfield), 
although switching to epipolarization illumination increases and 
clarifies the IGSS signal. Second, this method enables the discrimi-
nation of cell and tissue morphology with concomitant use of rou-
tine histological stains. Therefore, pathological irregularities and 
notable details can easily be revealed. Third, as opposed to IF, IGSS 
and IEL do not fade and therefore allow long-term documentation 
and re-examination of the section at a later date. 
For detection of the second antigen , mixed labeling using FITC-
conjugated MAb was two to three times more sensitive than a simi-
lar three-step IF procedure. For staining of the first Ag, however, 
we found a slightly lower sensitivity of IGSS as compared with IF. 
This has been encountered in several approaches (1), whereas others 
revealed a fairly high sensitivity for IGSS, especially when intracel-
lular antigens had been labeled (6 ,15). The difference in sensitiv-
ity of IGSS and IEL should therefore be taken into account when 
a mixed double-labeling protocol is being used . For this reason , 
it is advisable to stain the less abundant antigen by IEL. 
The mixed labeling achieved with brown IGSS and well-
311 
contrasting blue or red AP labeling is clearly visible and of better 
quality than mixed IEL. The latter is difficult to evaluate, espe-
cially in the case of a low-density second antigen that does not al-
low strong labeling. As a result, unequivocal distinction from single-
stained cells is hardly possible. In addition , it is difficult to find 
an appropriate substrate and enzyme combination for double IEL. 
In our hands, the combination of blue and red dyes often resulted 
in continuous change of hue, making assessment unfeasible. In 
general, mixed labeling with double IEL has not gained much ap-
plication and has been described as not reliable by several authors 
(4,17,19). The problems mentioned above can be avoided using the 
combination of IGSS and only one appropriate IEL. As described 
in the present study, the enzyme AP, rather than POX, appears 
to be most suitable for mixed labeling with IEL and IGSS, because 
it does not interfere with any endogenous POX activity. The basic 
chemophysical differences between both labels offer the advantage 
of avoiding mutual interference. This would also apply for the com-
bination of autoradiography and IEL (2), but in contrast to IGSS 
it is more laborious, time consuming, and hazardous. The applica-
tion of glucoxidase (21) does not seem appropriate for mixed labeling 
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either, because its diffuse color localization may interfere with the 
label of adjacent cells which, as a result, may be mistaken as dou-
ble labeled. 
The 5-nm gold particles that have previously been shown to be 
superior for IGSS (10) and which , unlike larger particles (e.g., 20 
nm), do not exhibit steric hindrance, are visible under epipolariza-
tion illumination. This facilitates the detection of double-labeled 
cells and even allows the semiquantitative assessment of antigen 
density. We could detect CD45+ cells (Fast B1ue+) exhibiting different 
levels ofHLA-DR antigen expression, as demonstrated by a low or 
high density of shining grains. The contrast between IGSS (under 
epipolarization illumination) and AP (brightfield illumination) can 
be used for computerized automated image analysis. In addition, 
both mixed labeling and double IF allow documentation with black-
and-white photographs, whereas double IEL requires colored 
documentation. 
It may be beneficial, for time reduction, to adapt the mixed 
labeling for use with a novel capillary action staining system re-
cently developed by Brigati et al. (5). Its advantages have already 
been demonstrated by Kumar (18) for single IGSS. Additional sav-
ing of time can also be achieved by simultaneous incubation of 
two reagents (e.g., streptavidin-gold and FITC-conjugated Ab). 
The present technique, developed to investigate the co-expression 
of antigens on immunocompetent hemopoietic cells, may very well 
be beneficially adapted to various other areas of research, such as 
the demonstration of overlapping hormone production in neuroen-
docrine cells or the simultaneous detection of viral or bacterial an-
tigens in infected cells. This would also apply for two-color DNA/ 
RNA in situ hybridization with non-radioactive probes or the simul-
taneous in situ detection of RNA/DNA and antigens (3,27). The 
present communication adds a further tool to supply the ongoing 
need for reliable and sensitive immunohistological techniques suit-
able for analysis of shared epitopes. 
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